Since its inception in 1980, the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Flow Cytometry Shared Resource has continuously offered state-of-the art cell sorting and analysis capabilities to the members of the SKCCC. These services are provided in a timely, flexible and affordable manner to Cancer Center members from across the entire medical campus. The resources provided by the Flow Core are not a duplication of those available elsewhere, and range from basic two color analyses, to complex sorting experiments involving up to 14 colors and 16 discrete parameters. Since the last renewal, the Flow Core has undergone the most dramatic update in its history. Specifically, the Core has acquired several new instruments, including two new high-end sorters. Both of these are high-speed, 14 color / 16 parameter Facs Aria units. The second unit is housed in a custom BSL-3 BioPROtect 111 Bio-Containment Enclosure, permitting users to sort un-fixed human cells under applicable CDC guidelines. The Core has also been relocated to a new, custom-designed physical space, a 1400 square ft. suite of three rooms on the fourth floor of the SKCCC Cancer Research Building (CRBI). Also, a new analysis unit, a special order research platform (SORP) LSR-II, with enhanced flow rates and detection capabilities has been added. Perhaps most significantly, two new experienced and dedicated personnel have been hired. Ms. Ada Tam serves as the Resource Manager;and Mr. Richard (Lee) Blosser who serves as co-manager and training Director. Their respective roles will be further detailed below. However, it should be noted that the Core now has the resources to provide training on each of the analysis units, cell sorting services, as well as back-end analysis assistance. Lay: Flow cytometry, is a method of sorting and measuring types of cells by fluorescent labeling of markers on the surface of the cells. It is sometimes referred to as FACS (Fluorescent Activated Cell Sorting) analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006973-51
Application #
8661008
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
51
Fiscal Year
2014
Total Cost
$173,195
Indirect Cost
$66,501
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Anchoori, Ravi K; Jiang, Rosie; Peng, Shiwen et al. (2018) Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer. ACS Omega 3:11917-11929
Shanbhag, Satish; Ambinder, Richard F (2018) Hodgkin lymphoma: A review and update on recent progress. CA Cancer J Clin 68:116-132
Palsgrove, Doreen N; Brosnan-Cashman, Jacqueline A; Giannini, Caterina et al. (2018) Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association. Mod Pathol 31:1787-1800
Adler, B L; Pezhouh, M K; Kim, A et al. (2018) Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. J Intern Med 283:568-577
Kelley, Dylan Z; Flam, Emily L; Guo, Theresa et al. (2018) Functional characterization of alternatively spliced GSN in head and neck squamous cell carcinoma. Transl Res 202:109-119
Knapp, Emily A; Dean, Lorraine T (2018) Consumer credit scores as a novel tool for identifying health in urban U.S. neighborhoods. Ann Epidemiol 28:724-729
Forde, Patrick M; Chaft, Jamie E; Smith, Kellie N et al. (2018) Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. N Engl J Med 378:1976-1986
Cottrell, Tricia R; Duong, Anh T; Gocke, Christopher D et al. (2018) PD-L1 expression in inflammatory myofibroblastic tumors. Mod Pathol 31:1155-1163
Fackler, Mary Jo; Sukumar, Saraswati (2018) Quantitation of DNA Methylation by Quantitative Multiplex Methylation-Specific PCR (QM-MSP) Assay. Methods Mol Biol 1708:473-496
Converse, Paul J; Almeida, Deepak V; Tasneen, Rokeya et al. (2018) Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer. PLoS Negl Trop Dis 12:e0006728

Showing the most recent 10 out of 2393 publications